Publications and communications of Yves BEGUIN

Book chapters or contributions to a collective book as author or co-author

GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc.

GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc.

Beguin, Y. (2008). Erythropoiesis. In C. Gasche, Anemia in inflammatory bowel disease (pp. 38-42). Uni-Med Verlag.

Beguin, Y., & Estatiev, R. (2008). Iron deficiency. In C. Gasche, Anemia in inflammatory bowel disease (pp. 42-47). Uni-Med Verlag.

Beguin, Y., & Vanstraelen, G. (2008). Prediction of response to recombinant human erythropoietin in the anemia of cancer. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.). Berlin - Heidelberg, Germany: Springer-Verlag.

Vanstraelen, G., & Beguin, Y. (2008). rhEPO in hematopoietic stem cell transplantation. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.) (pp. 583-614). Berlin - Heidelberg, Germany: Springer-Verla.

Beguin, Y., Dujardin, C., Piron, M., & Vanstraelen, G. (2006). Treatment of anaemia with erythropoietin. In C. Brugnara & C. Beaumont, ESH Scientific Updates. Disorders of Iron Homeostasis, Erythrocytes and erythropoiesis (pp. 180-209). Elsevier Science.

Beguin, Y. (2005). Erythropoietic agents and iron. In M. Aapro, C. Bokemeyer, ... H. Ludwig, ESO Scientific Updates, Vol. 6 (2nd ed). Anaemia in cancer (pp. 199-220). Elsevier Science.

Beguin, Y. (2005). Endogenous erythropoietin in the anemia of chronic disorders. In W. Weiss, V. R. Gordeuk, ... C. Hershko, Anemia of chronic disease (pp. 145-200). New York, United States - New York: Marcel Dekker.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers.

Beguin, Y. (2002). Predictive factors for response of anemia to recombinant human erythropoietin. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (pp. 263-286). Berlin - Heidelberg, Germany: Springer-Verlag.

Beguin, Y. (2001). Prediction of response to rHuEpo. In C. Bokemeyer & H. Ludwig, ESO Scientific Upadtes, Vol. 6 Anaemia in cancer (pp. 153-165). Elsevier Science.

Clement, J., De Bock, R., & Beguin, Y. (1994). Defective Epo production contributes to anemia persistent after ARF in nephropathia epidemica (NE). In Papadimitriou & Alexopoulos, Proceedings of the 3rd International Satellite Symposium on Acute Renal Failure (pp. 467-473). Thessaloniki, Greece: University Studio Press.

Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217).

Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication.

Beguin, Y., Huebers, H., Finch, C. A., Weber, G., & Roelandts, I. (1988). The regulation of liver iron metabolism. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 5 (pp. 542-547). Walter de Gruyter.

Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales.

Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage.

Beguin, Y., Delbrouck, J.-M., Roelandts, I., & Weber, G. (1984). Serum trace elements in hemoproliferative diseases. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 3 (pp. 383-389). Walter de Gruyter.

Articles accepted in reviewed journal

Lombardo, G., HAFRAOUI, K., Beguin, Y., & VERTENOEIL, G. (February 2024). Comment j’explore … une polyglobulie. Revue Médicale de Liège, 79 (2), 110 - 115.

Conrad, A., Beguin, Y., Guenounou, S., Le Bourgeois, A., Ménard, A.-L., Rialland, F., Layal, S., Mamez, A.-C., Yakoub-Agha, I., & El Cheikh, J. (2024). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 111 (25), 40-S49. doi:10.1016/j.bulcan.2023.05.007

Lacan, C., Lambert, J., Forcade, E., Robin, M., Chevallier, P., Loron, S., Bulabois, C.-É., Orvain, C., Ceballos, P., Daguindau, E., Charbonnier, A., Chalandon, Y., Bernard, M., Simand, C., Rubio, M.-T., Turlure, P., Maertens, J., Huynh, A., Loschi, M., ... Nguyen, S. (2024). Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry. Journal of Hematology and Oncology, 17, 2. doi:10.1186/s13045-023-01515-4

Ortí, G., Gras, L., Koster, L., Kulagin, A., Byrne, J., Apperley, J. F., Halaburda, K., Blau, I. W., Clark, A., Kröger, N., Griskevicius, L., Carlson, K., Collin, M., Bloor, A., Raiola, A. M., Blaise, D., Aljurf, M., López-Corral, L., Sakellari, I., ... Yakoub-Agha, I. (2024). Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT). Transplantation and Cellular Therapy, 30, 93.e1 - 93.e12. doi:10.1016/j.jtct.2023.09.019

Robin, M., Gras, L., Koster, L., Gagelmann, N., van Gorkom, G., Ederr, M., Itälä-Remes, M., Zuckerman, T., Beguin, Y., Schaap, N., Drozd-Sokolowska, J., Raj, K., Hayden, P. J., de Wreede, L. C., Battipaglia, G., Polverelli, N., Czerw, T., Hernandez Boluda, J. C., Kröger, N., ... McLornan, D. P. (2024). Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology, 204, 715 - 718. doi:10.1111/bjh.19214

Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366

COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3

Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085
* These authors have contributed equally to this work.

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.

Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (2023). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422

Chauvet, P., Paviglianiti, A., Labopin, M., Labussière, H., Boissel, N., Robin, M., Maillard, N., Ouachée-Chardin, M., Forcade, E., Poiré, X., Chantepie, S., Huynh, A., Bulabois, C., Leclerc, M., Maury, S., Chevallier, P., Cluzeau, T., Mear, J., Cornillon, J., ... Brissot, E. (2023). Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: A study of the SFGM-TC. Bone Marrow Transplantation, 58, 72-79. doi:10.1038/s41409-022-01846-9

El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435

Kaphan, E., Bettega, F., Forcade, E., Labussière-Wallet, H., Fegueux, N., Robin, M., Peffault De Latour, R., Huynh, A., Lapierre, L., Berceanu, A., Marcais, A., Debureaux, P.-E., Vanlangendonck, N., Bulabois, C.-E., Magro, L., Daniel, A., Galtier, J., Lioure, B., Chevallier, P., ... Thiebaut-Bertrand, A. (2023). Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC. Transplantation and Cellular Therapy, 362, 1 - e12. doi:10.1016/j.jtct.2023.02.020

Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901

Michel, C., Robin, M., Morisset, S., Blaise, D., Maertens, J., Chevalier, P., Castilla-Llorente, C., Forcade, E., Ceballos, P., Yakoug-Agha, I., Poire, X., Carre, M., Bay, J.-O., Beguin, Y., Loschi, M., Huynh, A., Guillerm, G., François, S., Mear, J.-B., ... D'Aveni, M. (2023). Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 58, 534 - 543. doi:10.1038/s41409-023-01931-7

Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192

Rey, G., Daguenet, E., Bonjean, P., Devillier, R., Fegueux, N., Forcade, E., Srour, M., Chevallier, P., Robin, M., Suarez, F., Micol, J.-B., Labussière-Wallet, H., Bilger, K., Daguindau, E., Bay, J.-O., Fayard, A., Bulabois, C.-E., Nguyen-Quoc, S., Genthon, A., ... Tavernier, E. (2023). Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC. Bone Marrow Transplantation, 58, 1331 - 1338. doi:10.1038/s41409-023-02082-5

Saccardi, R., Putter, H., Eikema, D., Busto, M., McGrath, E., Middelkoop, B., Adams, G., Atlija, M., Ayuk, A., Baldomero, H., Beguin, Y., del la Camara, R., Cedillo, A., Sureda, A., Chabannon, C., Corbacioglu, S., Dolstra, H., Duarte, R., Dulery, R., ... Snowden, J. (2023). Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 58, 659-666. doi:10.1038/s41409-023-01924-6

Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837
* These authors have contributed equally to this work.

Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464

Srour, M., Alsuliman, T., Labreuche, J., Bulabois, C., Chevalier, P., Daguindau, E., Forcade, E., François, S., Guillerm, G., Coiteux, V., Turlure, P., Beguin, Y., Yakoub-Agha, I., & Magro, L. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease: A prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 58, 401-406. doi:10.1038/s41409-022-01898-x

Tournilhac, O., van Gelder, M., Eikema, D., van Biezen, A., Dreger, P., Bornhäuser, M., Vucinic, V., Scheid, C., Cornelissen, J., Schroeder, T., Jindra, P., Sengeloev, H., Nguyen, S., Stelljes, M., Blau, I., Mayer, J., Paneesha, S., Chevalier, C., Forcade, E., ... Yakoub-Agha, I. (2023). The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009-2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 58, 621-624. doi:10.1038/s41409-023-01955-z

El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006

De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266

Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7

GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360
* These authors have contributed equally to this work.

Nabergoj, M., Mauff, K., Beelen, D., Ganser, A., Kröger, N., Stölzel, F., Finke, J., Passweg, J., Cornelissen, J., Schub, N., Veelken, J. H., Beguin, Y., Wilson, K., Zuckerman, T., Hunault-Berger, M., Lioure, B., Porras, R. P., Turlure, P., Kerre, T., ... Yakoub-Agha, I. (July 2022). Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 57, 1072 - 1078. doi:10.1038/s41409-022-01686-7

El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302

GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4
* These authors have contributed equally to this work.

SERVAIS, S., BEGUIN, Y., & BARON, F. (27 May 2022). Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia. Stem Cells Translational Medicine, 11 (5), 461-477. doi:10.1093/stcltm/szac015

BARZIN, A., Geurten, C., WILLEMS, E., Baron, F., Beguin, Y., & Servais, S. (May 2022). Maladie du greffon contre l’hôte aiguë et chronique après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 77 (5-6), 345 - 353.

Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.

HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8
* These authors have contributed equally to this work.

Albert, M. H., Sirait, T., Eikema, D.-J., Bakunina, K., Wehr, C., Suarez, F., Fox, M. L., Mahlaoui, N., Gennery, A. R., Lankester, A. C., Beier, R., Bernardo, M. E., Bigley, V., Lindemans, C. A., Burns, S. O., Carpenter, B., Dybko, J., Güngör, T., Hauck, F., ... Vinh, D. C. (2022). Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood, 140, 1635 - 1649. doi:10.1182/blood.2022015506

Averbuch, D., De Greef, J., Duréault, A., Wendel, L., Tridello, G., Lebeaux, D., Mikulska, M., Gil, L., Knelange, N., Zuckerman, T., Daguindau, E., Robin, C., Xhaard, A., Aljurf, M., Beguin, Y., Le Bourgeois, A., Botella-Garcia, C., Khanna, N., Van Praet, J., ... Styczynski, J. (2022). Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Clinical Infectious Diseases, 75, 88-97. doi:10.1093/cid/ciab866

BARON, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., BEGUIN, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology, 13, 827242. doi:10.3389/fimmu.2022.827242

BAYOUDH, F., JASPERS, A., Azerad, M.-A., SOMJA, J., Marechal, H., & Beguin, Y. (2022). A rare case of massive myocardial infiltration by a disseminated extra-nodal NK/T-cell lymphoma. EJHaem, 3, 547-548.

Le Calvez, B., Tessoullin, B., Renaud, L., Botella-Garcia, C., Srour, M., Le Gouill, S., Guillerm, G., Gressin, R., Nguyen Quoc, S., Furst, S., Chauchet, A., Sibon, D., Lewalle, P., Poiré, X., Maillard, N., Villate, A., Loschi, M., Paillassa, J., Beguin, Y., ... Le Bourgeois, A. (2022). Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica, 61, 1332 - 1338. doi:10.1080/0284186X.2022.2130709

Narinx, J., Houbiers, M., Seidel, L., & Beguin, Y. (2022). Adherence to Sars-CoV2 vaccination in hematological patients. Frontiers in Immunology, 13, 994311. doi:10.3389/fimmu.2022.994311

Onida, F., Sbianchi, G., Radujkovic, A., Sockel, K., Kröger, N., Sierra, J., Socié, G., Cornelissen, J., Poiré, X., Raida, L., Bourhis, J.-H., Finke, J., Passweg, J., Salmenniemi, U., Schouten, H. C., BEGUIN, Y., Martin, S., Deconinck, E., Ganser, A., ... Yakoub-Agha, I. (2022). Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. Bone Marrow Transplantation, 57, 896-902. doi:10.1038/s41409-021-01555-9

Pochon, C., Detrait, M., Dalle, J.-H., Michel, G., Dhédin, N., Chalandon, Y., Brissot, E., Forcade, E., Sirvent, A., Izzadifar-Legrand, F., Michallet, M., Renard, C., Yakoub-Agha, I., Gonzales, F., Bay, J.-O., Kanold, J., Cornillon, J., Bulabois, C. E., Angoso, M., ... Rubio, M.-T. (2022). Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). Journal of Cancer Research and Clinical Oncology, 148, 2083-2097. doi:10.1007/s00432-021-03761-w

Poiré, X., Graux, C., ORY, A., Herman, J., Baron, F., Schoemans, H., Lewalle, P., De Becker, A., Deeren, D., Berneman, Z., Kerre, T., Zachée, P., Selleslag, D., & Beguin, Y. (2022). Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS). Bone Marrow Transplantation, 57, 116-118. doi:10.1038/s41409-021-01464-x

Teyssier, A.-C., Michel, G., Jubert, C., Rialland, F., Visentin, S., Ouachée, M., Bilger, K., Gandemer, V., Beguin, Y., Marie-Cardine, A., Chalandon, Y., Ansari, M., Baumstarck, K., Loundou, A., Dalle, J.-H., & Sirvent, A. (2022). Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial. Transplantation and Cellular Therapy, 28, 780.e1 - 780.e7. doi:10.1016/j.jtct.2022.08.019

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323

VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154

Bay, J. O., Beguin, Y., CARPENTIER, A., Dard, C., Guillaume, T., Labussiere-Wallet, H., Lacassagne, M. N., Sauze, S., Yakoub-Agha, I., & Chalandon, Y. (2021). Comment faire face à un évènement inattendu pouvant modifier l’activité normale de thérapie cellulaire? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer, 108, 20-S25. doi:10.1016/j.bulcan.2021.05.002

BEGUIN, Y. (2021). L’Institut de Cancérologie Arsène Burny (ICAB) et son nouveau bâtiment du Centre Intégré d’Oncologie (CIO) au CHU de Liège. Revue Médicale de Liège, 76, 300-306.

Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3
* These authors have contributed equally to this work.

Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.

Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M., & Caers, J. (2021). A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma. Journal of hematology & oncology, 14 (1), 183. doi:10.1186/s13045-021-01171-6

Ehx, G.* , Ritacco, C.* , HANNON, M., DUBOIS, S., Delens, L., WILLEMS, E., SERVAIS, S., Drion, P., BEGUIN, Y., & Baron, F. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation, 21, 2662-2674. doi:10.1111/ajt.16505
* These authors have contributed equally to this work.

Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults. Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Acta Clinica Belgica, 26, 1-14. doi:10.1080/17843286.2021.1876310

Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Belgian Journal of Hematology, 12, 112-127.

Kröger, N., Sbianchi, G., Sirait, T., Wolschke, C., Beelen, D., Passweg, J., Robin, M., Vrhovac, R., Helbig, G., Sockel, K., Conneally, E., Rubio, M. T., Beguin, Y., Finke, J., Bernasconi, P., Morozova, E., Clausen, J., von dem Borne, P., Schaap, N., ... Yakoub-Agha, I. (2021). Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia, 35, 3551-3580. doi:10.1038/s41375-021-01276-4

LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320

Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J. (2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13 (12), 3072. doi:10.3390/cancers13123072

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.

Miano, M., Eikema, D.-J., de la Fuente, J., Bosman, P., Ghavamzadeh, A., Smiers, F., Sengeløv, H., Yesilipek, A., Formankova, R., Bader, P., Díaz Pérez, M. Á., Bertrand, Y., Niemeyer, C., Diallo, S., Ansari, M., Bykova, T. A., Faraci, M., Bonanomi, S., Gozdzik, J., ... Dufour, C. (2021). Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplantation and Cellular Therapy, 27 (3), 274.e1-274.e5. doi:10.1016/j.jtct.2020.12.024

Narinx, J., SERVAIS, S., BARON, F., BEGUIN, Y., & WILLEMS, E. (2021). Allogreffes de cellules souches hématopoïétiques : principes généraux et progrès récents. Revue Médicale de Liège, 76, 464-469.

Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x

PIROTTE, M., Fillet, M., SEIDEL, L., JASPERS, A., Baron, F., & Beguin, Y. (2021). Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. American Journal of Hematology, 96 (10), 1275-1286. doi:10.1002/ajh.26300

Ritacco, C.* , Ehx, G.* , GREGOIRE, C., Daulne, C., WILLEMS, E., SERVAIS, S., BEGUIN, Y., & Baron, F. (2021). High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 56, 1828-1841. doi:10.1038/s41409-021-01221-0
* These authors have contributed equally to this work.

SCHEEN, A., BEGUIN, Y., & JERUSALEM, G. (2021). L’oncologie, à un tournant de son histoire. Revue Médicale de Liège, 76, 297-299.

Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488.

Xhaard, A., Xhaard, C., d'Aveni, M., Salvator, H., Chabi-Charvillat, M.-L., Coman, T., BEGUIN, Y., Chalandon, Y., Poiré, X., Loschi, M., Paillard, C., Bruno, B., Ceballos, P., Dalle, J.-H., Bilger, K., Bay, J.-O., Robin, M., N'Guyen-Quoc, S., & Rubio, M.-T. (2021). Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation : a SFGM-TC multicentre cohort study. British Journal of Haematology, 192, 121-e135. doi:10.1111/bjh.17260

Vandenhove, B., Canti, L., Schoemans, H., Beguin, Y., Baron, F., Graux, C., Kerre, T., & SERVAIS, S. (21 October 2020). How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology, 11, 583564. doi:10.3389/fimmu.2020.583564

Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762

VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077

Azerad, M.-A., BAYOUDH, F., Weber, T., Minon, J.-M., Ketelsleggers, O., HOYOUX, M., Ren, X., Kaye, O., De Marneffe, N., Fraipont, V., Masset, C., Bouillon, A.-S., JASPERS, A., Tebache, M., D'Hoen, G., Habibi, A., Efira, A., Thachil, J., Deckmyn, H., & BEGUIN, Y. (2020). Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes. EJHaem, 1 (jha 2.74), 338-341. doi:10.1002/jha2.74

Dhédin, N., Paillard, C., Dalle, J.-H., Ouachée, M., Buchbinder, N., Brissot, E., BEGUIN, Y., Masouridi-Levrat, S., Yakoub-Agha, I., Bernit, E., & Pondarre, C. (2020). Allogreffe de cellules souches hématopoïétiques dans la drépanocytose de l'enfant et de l'adulte : indications et modalités. Bulletin du Cancer, 107, 925-933. doi:10.1016/j.bulcan.2020.06.003

Dubois, V., Amokrane, K., Beguin, Y., Bruno, B., Chevallier, P., Delbos, F., Devillier, R., Giannoli, C., Guidicelli, G., Harif, M., Loiseau, P., Rouzaire, P.-O., Varlet, P., Yakoub-Agha, I., & Nguyen, S. (2020). Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 107 (Suppl. 1), 72-84. doi:10.1016/j.bulcan.2019.07.011

HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315.

Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34.

Mamez, A.-C., Dupont, A., Blaise, D., Chavallier, P., Forcade, E., Ceballos, P., Mohty, M., Suarez, F., BEGUIN, Y., Peffault de Latour, R., Rubio, M.-T., Tournilhac, O., & Nguyen, S. (2020). Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Journal of Hematology and Oncology, 13, 56. doi:10.1186/s13045-020-00892-4

Roex, G., Feys, T., BEGUIN, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies : An Update of the Pivotal Clinical Trial Center. Pharmaceutics, 12, 194. doi:10.3390/pharmaceutics12020194

Snowden, J. A., Saccardi, R., Orchard, K., Ljungman, P., Duarte, R. F., Labopin, M., McGrath, E., Brook, N., Ruiz de Elvira, C., Gordon, D., Poirel, H. A., Ayuk, F., Beguin, Y., Bonifazi, F., Gratwohl, A., Milpied, N., Moore, J., Passweg, J., Rizzo, J. D., ... Putter, H. (2020). Benchmarking of Survival Outcomes following Haematopoietic Stem Cell Transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 55, 681-694. doi:10.1038/s41409-019-0718-7

Vandenhove, B.* , Canti, L.* , Schoemans, H., BEGUIN, Y., BARON, F., WILLEMS, E., Graux, C., Kerre, T.* , & SERVAIS, S.*. (2020). Acute graft-versus-host disease: diagnosis, pathophysiology and prevention. Belgian Journal of Hematology, 11 (4), 159-173.
* These authors have contributed equally to this work.

Antoine-Poirel, H., Vanspauwen, M., Macq, G., De Geyndt, A., Maertens, J., WILLEMS, E., Selleslag, D., Poiré, X., Theunissen, K., Graux, C., Kerre, T., Zachée, P., Meuleman, N., De Becker, A., Verlinden, A., Van Obbergh, F., Schuermans, C., De Wilde, V., JASPERS, A., ... Beguin, Y. (2019). Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres. Bone Marrow Transplantation, 54, 1434-1442. doi:10.1038/s41409-019-0458-8

Caulier, A., Drumez, E., Gauthier, J., Robin, M., Blaise, D., Beguin, Y., Michallet, M., Chevallier, P., Bay, J.-O., Vigouroux, S., Desbrosses, Y., Cornillon, J., Nguyen, S., Dauriac, C., de Latour, R. P., Lioure, B., Rohrlich, P.-S., Carré, M., Bourhis, J.-H., ... Yakoub-Agha, I. (2019). Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC. Current Research in Translational Medicine, 67, 8-15. doi:10.1016/j.retram.2018.08.003

Cremers, E., de Witte, T., de Wreede, L., Eikema, D.-J., Koster, L., van Biezen, A., Finke, J., Socié, G., Beelen, D., Maertens, J., Nagler, A., Kobbe, G., Ziagkos, D., Itälä-Remes, M., Gedde-Dahl, T., Sierra, J., Niederwieser, D., Ljungman, P., Beguin, Y., ... Kröger, N. (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *. Leukemia and Lymphoma, 60, 2404-2414. doi:10.1080/10428194.2019.1594215

Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007

Engel, N., Rovo, A., Badoglio, M., Labopin, M., Basak, G. W., BEGUIN, Y., Guyotat, D., Ljungman, P., Nagler, A., Schattenberg, A., Schroeder, T., Schroyens, W., Tischer, J., Socie, G., Kolb, H.-J., Tichelli, A., Salooja, N., & Duarte, R. F. (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33, 508-517. doi:10.1038/s41375-018-0218-6

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046

Fayard, A., Daguenet, E., Blaise, D., Chevallier, P., Labussière, H., Berceanu, A., Yakoub-Agha, I., Socié, G., Charbonnier, A., Suarez, F., Huynh, A., Mercier, M., Bulabois, C.-E., Lioure, B., Chantepie, S., Beguin, Y., Bourhis, J.-H., Malfuson, J.-V., Clément, L., ... Cornillon, J. (2019). Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 54, 1586-1594. doi:10.1038/s41409-019-0475-7

Feyx, T., Roex, G., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2019). Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond. Belgian Journal of Hematology, 10, 301-310.

Fitzgerald, S. P., Grote Beverborg, N., Beguin, Y., Artunc, F., Falhammar, H., & Bean, N. G. (2019). Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery. Physiological Reports, 7 (12), 14153. doi:10.14814/phy2.14153

Grégoire, C., Ritacco, C., Hannon, M., SEIDEL, L., Delens, L., Belle, L., DUBOIS, S., Veriter, S., LECHANTEUR, C., BRIQUET, A., Servais, S., Ehx, G., Beguin, Y., & Baron, F. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology, 10, 619. doi:10.3389/fimmu.2019.00619

Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., Bay, J.-O., Poiré, X., Maillard, N., Leclerc, M., Daguindau, E., Beguin, Y., Rubio, M. T., & Gyan, E. (2019). Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 25, 2366-2374. doi:10.1016/j.bbmt.2019.07.013

JASPERS, A., & Beguin, Y. (2019). Erythropoiesis and iron metabolism after hematopoietic stem cell transplantation. Belgian Journal of Hematology, 10, 89-95.

Muller, J., Duray, E., Lejeune, M., DUBOIS, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V., BEGUIN, Y., Heusschen, R., & CAERS, J. (2019). Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts. Cancers, 11 (2), 261. doi:10.3390/cancers11020261

Nagler, A., Labopin, M., Dholaria, B., Niittyvuopio, R., Maertens, J., Poiré, X., Cornelissen, J., Reményi, P., Bourhis, J. H., Beguin, Y., Malladi, R., Kerre, T., Schroyens, W., Savani, B. N., & Mohty, M. (2019). Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Advances, 3 (13), 1950-1960. doi:10.1182/bloodadvances.2019000030

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., Pugnet, G., Badoglio, M., Lansiaux, P., Ibrahim, Y.-A., Beguin, Y., & Farge, D. (2019). Indications de l'autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques. Bulletin du Cancer, 106 (Suppl. 1), 92-101. doi:10.1016/j.bulcan.2018.11.002

GREGOIRE, C., BRIQUET, A., PIRENNE, C., LECHANTEUR, C., LOUIS, E.* , & BEGUIN, Y.*. (November 2018). Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II study. Digestive and Liver Disease, 50 (11), 1251-1255. doi:10.1016/j.dld.2018.08.015
* These authors have contributed equally to this work.

Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175

Aapro, M. S., Beguin, Y., Bokemeyer, C., Dicato, M., Gascon, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewod, T., Ludwig, H., Osterborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., & Herrstedt, J. (2018). Management of anaemia and iron deficiency in patients with cancer : ESMO Clinical Practice Guidelines. Annals of Oncology, 29, 96-110. doi:10.1093/annonc/mdx758

Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A., & Dreger, P. (2018). High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party. American Journal of Hematology, 93 (1), 40-46. doi:10.1002/ajh.24927

Caers, J., Garderet, L., Kortum, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y., Ludwig, H., Larocca, A., Driessen, C., Dimopoulos, M. A., Boccadoro, M., Gramatzki, M., Zweegman, S., Einsele, H., Cavo, M., ... Engelhardt, M. (2018). European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica, 103, 1172-1184. doi:10.3324/haematol.2018.189159

Decroocq, J., Itzykson, R., Vigouroux, S., Michallet, M., Yakoub-Agha, I., Huynh, A., Beckerich, F., Suarez, F., Chevallier, P., Nguyen-Quoc, S., Ledoux, M.-P., Clement, L., Hicheri, Y., Guillerm, G., Cornillon, J., Contentin, N., Carre, M., Maillard, N., Mercier, M., ... Dhedin, N. (2018). Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire. American Journal of Hematology, 93 (3), 416-423. doi:10.1002/ajh.25004

Devos, T., BEGUIN, Y., Noens, L., Van Eygen, K., Zachée, P., Mineur, P., Knoops, L., Doyen, C., Theunissen, K., Benghiat, F. S., Reusens, M., & Pluymers, W. (2018). Disease and treatment characteristics of polycythaemia vera patients in Belgium : results from a scientific survey. European Journal of Haematology, 100, 361-366. doi:10.1111/ejh.13022

Ehx, G., SOMJA, J., Warnatz, H.-J., Ritacco, C., HANNON, M., Delens, L., Fransolet, G., DELVENNE, P., Muller, J., BEGUIN, Y., Lehrach, H., Belle, L., Humblet-Baron, S., & BARON, F. (2018). Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Frontiers in Immunology, 9, 1943. doi:10.3389/fimmu.2018.01943

Gauthier, J., Poiré, X., Gac, A.-C., Leclerc, M., Guillaume, T., Chalandon, Y., Nguyen, S., Forcade, E., Régny, C., Bay, J.-O., Bazarbachi, A., Rohrlich, P.-S., Huynh, A., Farhi, J., Marchand, T., Malfuson, J.-V., Pilorge, S., Labussière-Wallet, H., Renard, C., ... Yakoub-Agha, I. (2018). Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 53 (4), 400-409. doi:10.1038/s41409-017-0018-z

HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8

Heusschen, R., Muller, J., Duray, E., WITHOFS, N., Bolomsky, A., Baron, F., Beguin, Y., Menu, E., Ludwig, H., & Caers, J. (2018). Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Leukemia and Lymphoma, 59, 14-28. doi:10.1080/10428194.2017.1323272

Laureys, G., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Van de Velde, A. (2018). A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurologica Belgica, 118 (2), 161-168. doi:10.1007/s13760-018-0905-0

Lewalle, P., & Beguin, Y. (2018). Extracorporeal photochemotherapy for graft versus host disease : Where we are now and where are we going ! Belgian Journal of Hematology, 9, 254-265.

McLornan, D. P., Szydlo, R., Robin, M., van Biezen, A., Koster, L., Blok, H. J. P., Van Lint, M. T., Finke, J., Vitek, A., Carlson, K., Griskevicius, L., Holler, E., Itala-Remes, M., Schaap, M., Socie, G., Bay, J.-O., BEGUIN, Y., Bruno, B., Cornelissen, J. J., ... Kroger, N. (2018). Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. British Journal of Haematology, 182, 418-422. doi:10.1111/bjh.15407

Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., Lejeune, M., Léonard, A., Marty, C., Hempel, U., Baron, F., BEGUIN, Y., Cohen-Solal, M., Ludwig, H., Heusschen, R., & CAERS, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease. Haematologica, 103, 1359-1368. doi:10.3324/haematol.2017.185397

Paviglianiti, A., Tozatto Maio, K., Rocha, V., Gehlkopf, E., Milpied, N., Esquirol, A., Chevallier, P., Blaise, D., Gac, A.-C., Leblond, V., Cahn, J. Y., Abecasis, M., Zuckerman, T., Schouten, H., Gurman, G., Rubio, M. T., Beguin, Y., Corral, L. L., Nagler, A., ... Ruggeri, A. (2018). Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. Biology of Blood and Marrow Transplantation, 24, 2265-2270. doi:10.1016/j.bbmt.2018.07.019

Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003
* These authors have contributed equally to this work.

Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020

Trento, C., Bernardo, M. E., Nagler, A., Kuçi, S., Bornhäuser, M., Köhl, U., Strunk, D., Galleu, A., Sanchez-Guijo, F., Gaipa, G., Introna, M., Bukauskas, A., Le Blanc, K., Apperley, J., Roelofs, H., Van Campenhout, A., Beguin, Y., Kuball, J., Lazzari, L., ... Dazzi, F. (2018). Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 24, 2365-2370. doi:10.1016/j.bbmt.2018.07.015

Van de Velde, A., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Laureys, G. (2018). A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis. Belgian Journal of Hematology, 9, 167-174.

Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001

Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yaňez San Segundo, L., Pabst, T., Özçelik, T., Klyasova, G., Donnini, I., Wu, D., Gülbas, Z., Zuckerman, T., Botelho De Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., De La Camara, R., ... Cesaro, S. (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical Infectious Diseases, 65 (11), 1819-1828. doi:10.1093/cid/cix646

Ehx, G., Fransolet, G., De Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Oncoimmunology, 6:e1314425. doi:10.1080/2162402X.2017.1314425

Gauthier, J., Castagna, L., Garnier, F., Guillaume, T., Socié, G., Maury, S., Maillard, N., Tabrizi, R., Marchand, T., Malfuson, J.-V., Gac, A.-C., Gyan, E., Mercier, M., BEGUIN, Y., Delage, J., Turlure, P., Marcais, A., Nguyen, S., Dulery, R., ... Blaise, D. (2017). Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 52, 689-696. doi:10.1038/bmt.2016.34

GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864

Heidenreich, S., Ziagkos, D., De Wreede, L., Van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schleuning, M., Beelen, D., Tischer, J., Nagler, A., Glass, B., Maertens, J., Yanez, L., BEGUIN, Y., Sill, H., Scheid, C., ... Kröger, N. (2017). Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT. Biology of Blood and Marrow Transplantation, 23, 44-52. doi:10.1016/j.bbmt.2016.09.027

Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74.

Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Liénard, A., Merckaert, I., Reynaert, C., Slachmuylder, J.-L., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. Psycho-oncology, 26 (12), 2086-2093. doi:10.1002/pon.4424

Libert, Y., Borghgraef, C., BEGUIN, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Lienard, A., Merckaert, I., Slachmuylder, J., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study. Psycho-oncology, 26, 118-124. doi:10.1002/pon.4108

Magro, L., Forcade, E., Giraud, C., Granata, A., Parquet, N., Rohrlich, P.-S., Terriou, L., Yakoub-Agha, I., & Beguin, Y. (2017). Prise en charge de la maladie du greffon contre l'hôte chronique : Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 104S, 145-S168. doi:10.1016/j.bulcan.2017.10.023

Roth-Guepin, G., Canaani, J., Ruggeri, A., Labopin, M., Finke, J., Cornelissen, J. J., Delage, J., Stuhler, G., Rovira, M., Potter, M., Stadler, M., Veelken, H., Cahn, J. Y., Collin, M., Beguin, Y., Giebel, S., Nagler, A., & Mohty, M. (2017). Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT. Oncotarget, 8 (68), 112972-112979. doi:10.18632/oncotarget.22934

Roux, C., Tifratene, K., Socié, G., Galambrun, C., Bertrand, Y., Rialland, F., Jubert, C., Pochon, C., Paillard, C., Sirvent, A., Nelken, B., Vannier, J.-P., Freycon, C., BEGUIN, Y., Raus, N., Yakoub-Agha, I., Mohty, M., Dalle, J.-H., Michel, G., ... Rohrlich, P.-S. (2017). Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 52, 678-682. doi:10.1038/bmt.2016.360

SERVAIS, S., Hannon, M., Peffault de Latour, R., Socie, G., & BEGUIN, Y. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections. Stem Cell Investigation, 4, 40.

Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397

Van Obbergh, F., Knoops, L., Devos, T., BEGUIN, Y., Graux, C., Benghiat, S., Kargar-Samani, K., Bauwens, D., Efira, A., Dubois, C., Springael, C., Montfort, L., Connerotte, T., Delannoy, A., & Wallemacq, P. (2017). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry, 50, 452-454. doi:10.1016/j.clinbiochem.2016.12.006

Vrancken, L., Delens, L., BEGUIN, Y., BARON, F., & SERVAIS, S. (2017). Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 11, 23-31.

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

Belle, L.* , Fransolet, G.* , Somja, J., BINSFELD, M., Delvenne, P., Drion, P., Hannon, M., BEGUIN, Y., Ehx, G.* , & Baron, F.*. (12 December 2016). Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease. PLoS ONE, 11, 0167997. doi:10.1371/journal.pone.0167997
* These authors have contributed equally to this work.

Fransolet, G.* , Ehx, G.* , SOMJA, J., Delens, L., Hannon, M., Muller, J., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., DELVENNE, P., BEGUIN, Y., Conteduca, G.* , & BARON, F.*. (04 July 2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology and Oncology, 9, 53. doi:10.1186/s13045-016-0281-2
* These authors have contributed equally to this work.

SERVAIS, S., BEGUIN, Y., Delens, L., Ehx, G., Fransolet, G., Hannon, M., WILLEMS, E., Humblet-Baron, S., Belle, L., & Baron, F. (11 May 2016). Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs, 9, 957-972. doi:10.1080/13543784.2016.1182498

Grégoire, C., GUIOT, J., Vertenoeil, G., WILLEMS, E., HAFRAOUI, K., CORHAY, J.-L., LOUIS, R., & BEGUIN, Y. (February 2016). Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma. Acta Clinica Belgica, 71, 428-430. doi:10.1080/17843286.2015.1122872

Baron, F., & Beguin, Y. (2016). Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? Bone Marrow Transplantation, 51, 640-42. doi:10.1038/bmt.2016.38

Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcene, A., Van Valckenborgh, E., BARON, F., BEGUIN, Y., CAERS, J., & Heusschen, R. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7, 37931-37943. doi:10.18632/oncotarget.9270

CAERS, J., de Larrea, C., Leleu, X., Heusschen, R., Zojer, N., Decaux, O., Kastritis, E., Minnema, M., Jurczyszyn, A., Beguin, Y., Wäsch, R., Palumbo, A., Dimopoulos, M., Mateos, M. V., Ludwig, H., & Engelhardt, M. (2016). The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. Oncologist, 21, 333-342. doi:10.1634/theoncologist.2015-0303

El Cheikh, J., Sfumato, P., Sobh, M., Fegueux, N., Mohty, M., Vigouroux, S., BEGUIN, Y., Yakoub-Agha, I., Socié, G., Cornillon, J., Mercier, M., Bay, J., Blaise, D., Michallet, M., & Peffault de Latour, R. (2016). Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell transplantation (SFGM-TC). Haematologica, 101, 262-265.

Guièze, R., Damaj, G., Pereira, B., Robin, M., Chevallier, P., Michallet, M., Vigouroux, S., BEGUIN, Y., Blaise, D., Roosweil, D., Thiebaut, A., Rohrlich, P.-S., Huynh, A., Cornillon, J., Contentin, N., Suarez, F., Lioure, B., Mohty, M., Maillard, N., ... yakoub-Agha, I. (2016). Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Biology of Blood and Marrow Transplantation, 22, 240-247. doi:10.1016/j.bbmt.2015.07.037

Heusschen, R.* , Muller, J.* , Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., BEGUIN, Y., Menu, E., Cohen-Solal, M., & CAERS, J. (2016). SRC Kinase Inhibition with Saracatinib Limits the Development of Osteolytic Bone Disease in Multiple Myeloma. Oncotarget, 7, 30712-30729. doi:10.18632/oncotarget.8750
* These authors have contributed equally to this work.

JASPERS, A., Bouhya, S., Belaiche, S., Chevallier, P., Hermet, E., Hospital-Gustems, C., Michallet, M., Rialland, F., Samsonova, O., Sirvent, A., Yakoub-Agha, I., Rohrlich, P.-S., & BEGUIN, Y. (2016). Evaluation et prise en charge de la surcharge en fer post-greffe recommandations de la SFGM-TC. Bulletin du Cancer, 103, 255-S266. doi:10.1016/j.bulcan.2016.09.003

LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y

Mamez, Levy, V., Chevallier, P., Blaise, D., Vigouroux, S., Xhaard, A., Fegueux, N., Contentin, N., BEGUIN, Y., Ifrah, N., Bulabois, C., Suarez, F., Yakoub-Agha, I., Turlure, P., Deconink, E., Lamy, T., Cahn, J.-Y., Huynh, A., Maury, S., ... Nguyen, S. (2016). Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 51, 358-364. doi:10.1038/bmt.2015.280

Pirotte, M., GUIOT, J., BEGUIN, Y., & Louis, R. (2016). L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit. Revue Médicale de Liège, 71 (11), 488-494.

SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235.

VALDES SOCIN, H. G., SID, S., LUTTERI, L., POLUS, M., Louis, E., Beguin, Y., & Beckers, A. (2016). Le syndrome thyro-gastrique auto-immun : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 21 (4), 40-45.

JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100

HANNON, M., BEGUIN, Y., Ehx, G., SERVAIS, S., SEIDEL, L., Graux, C., Maertens, J., Kerre, T., Daulne, C., de Bock, M., Fillet, M., ORY, A., WILLEMS, E., GOTHOT, A., Humblet-Baron, S., & BARON, F. (15 July 2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research, 21 (14), 3131-9. doi:10.1158/1078-0432.CCR-14-3374

WITHOFS, N., NANNI, C., SIMONI, P., FANTI, S., BEGUIN, Y., & CAERS, J. (20 March 2015). Imaging myeloma and related monoclonal plasma cell disorders using MRI, low dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging, 3, 95-109. doi:10.1007/s40336-015-0119-x

Baron, F., Zachée, P., Maertens, J., Kerre, T., ORY, A., SEIDEL, L., Graux, C., Lewalle, P., Van Gelder, M., Theunissen, K., WILLEMS, E., Emonts, M.-P., De Becker, A., & Beguin, Y. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Journal of Hematology and Oncology, 8, 4. doi:10.1186/s13045-014-0098-9

Basak, G., Wiktor-Jedrzejczak, W., Labopin, M., Schoemans, H., Ljungman, P., Kobbe, G., Beguin, Y., Lang, P., Koenecke, C., Sykora, K., te Boome, L., van Biezen, A., van der Werf, S., Mohty, M., de Witte, T., Marsh, J., Dreger, P., Kröger, N., Duarte, R., & Ruutu, T. (2015). Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT. American Journal of Transplantation, 15, 705-714. doi:10.1111/ajt.13017

Beguin, Y., Selleslag, D., Meers, S., Graux, C., Bries, G., Deeren, D., Vrelust, I., Ravoet, C., Theunissen, K., Voelter, V., Potier, H., Trullemans, F., Noens, L., & Mineur, P. (2015). Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey. Acta Clinica Belgica, 70, 34-43. doi:10.1179/2295333714Y.0000000102

Benghiat, F., Beguin, Y., Dessars, B., Devos, T., Lewalle, P., Mineur, P., Straetmans, N., Van Eygen, K., Verhoef, G., & Knoops, L. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Belgian Journal of Hematology, 6 (1), 16-32.

Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.

Devos, T., Zachée, P., Bron, D., Noens, L., Van Droogenbroeck, J., Mineur, P., Beguin, Y., Berneman, Z., Benghiat, F. S., Kentos, A., Chatelain, C., Demuynck, H., Lemmens, J., Van Eygen, K., Theunissen, K., Trullemans, F., Pierre, P., Pluymers, W., & Knoops, L. (2015). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica, 70 (2), 105-111. doi:10.1179/2295333714Y.0000000097

Ehx, G.* , Hannon, M.* , BEGUIN, Y., Humblet-Baron, S.* , & BARON, F.*. (2015). Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets. Oncotarget, 6, 43255-43266. doi:10.18632/oncotarget.6486
* These authors have contributed equally to this work.

Gauthier, J., Damaj, G., Langlois, C., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., N'guyen, S., Bories, P., Blaise, D., Cornillon, J., Clavert, A., Mohty, M., Huynh, A., Thiébaut-Bertrand, A., Vigouroux, S., Duhamel, A., & Yakoub-Agha, I. (2015). Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the Société Française de Greffe de Moelle et Thérapies Cellulaires. Transplantation, 99 (8), 1672-1680.

Guillaume, T., Beguin, Y., Tabrizi, R., Nguyen, S., Blaise, D., Deconinck, E., Redjoul, R., Cornillon, J., Guillerm, G., Contentin, N., Sirvent, A., Turlure, P., Salmon, A., Huynh, A., Francois, S., Peffault de Latour, R., Yakoub-Agha, I., & Mohty, M. (2015). Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). European Journal of Haematology, 94, 265-269. doi:10.1111/ejh.12430

Halter, J., Michael, W., Schüpbach, W., Mandel, H., Casali, C., Orchard, K., Collin, M., Valcarcel, D., Rovelli, A., Filosto, M., Dotti, M., Marotta, G., Pintos, G., Barba, P., Accarino, A., Ferra, C., Illa, I., Beguin, Y., Bakker, J., ... Hirano, M. (2015). Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain: a Journal of Neurology, 138, 2847-2858. doi:10.1093/brain/awv226

Leclerc, M., Suarez, F., Noël, M.-P., Vekhoff, A., Troussard, X., Claisse, J.-F., Thieblemont, C., Maloisel, F., Beguin, Y., Tamburini, J., Barbe, C., & Delmer, A. (2015). Rituximab therapy for hairy cell leukemia : a retrospective study of 41 cases. Annals of Hematology, 94, 89-95. doi:10.1007/s00277-014-2175-0

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597

SERVAIS, S., Baron, F., & BEGUIN, Y. (2015). Impact of graft source and composition on outcomes after allogeneic stem cell transplantation. Belgian Journal of Hematology, 6 (4), 162-168.

Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394

SERVAIS, S., Menten-Dedoyart, C., Beguin, Y., SEIDEL, L., Gothot, A., Daulne, C., WILLEMS, E., Delens, L., Humblet-Baron, S., Hannon, M., & Baron, F. (2015). Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE, 10 (6), 0130026. doi:10.1371/journal.pone.0130026

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.

MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164

Delens, L., Jouret, F., DETRY, O., Beguin, Y., & Krzesinski, J.-M. (27 August 2014). Intérêt des cellules stromales mésenchymateuses en transplantation d’organes solides. Revue Médicale Suisse, 10, 1538-1543.

De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017

Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279

CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918

CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233

Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9

Battisti, O., & Beguin, Y. (2014). A propos de l'encéphalopathie du nouveau-né. Percentile, 19, 8-9.

Beguin, Y., Aapro, M. S., Ludwig, H. P., Mizzen, L., & Osterborg, A. C. (2014). Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review. Critical Reviews in Oncology/Hematology, 89, 1-15. doi:10.1016/j.critrevonc.2013.10.008

Beguin, Y., & JASPERS, A. (2014). Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on Pharmacotherapy, 15, 2087-2103. doi:10.1517/14656566.2014.953928

Belaiche, S., Yafour, N., Balcaen, S., Beguin, Y., Borel, C., Bruno, B., Godin, S., Labussière-Wallet, H., Sanhamut, N., Charbonnier, A., de Berranger, E., Konopacki-Potet, J., Turlure, P., & Yakoub-Agha, I. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l'hôte : rapport de la SFGM-TC. Pathologie Biologie, 62, 197-203. doi:10.1016/j.patbio.2014.05.010

Binsfeld, M., Beguin, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Heusschen, R., Drion, P., Zilberberg, J., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. PLoS ONE, 113764. doi:10.1371/journal.pone.0113764

Binsfeld, M., Fostier, K., Muller, J., Baron, F., Schots, R., Beguin, Y., Heusschen, R., & CAERS, J. (2014). Cellular immunotherapy in multiple myeloma : lessons from preclinical models. Biochimica et Biophysica Acta - Reviews on Cancer, 1846, 392-404. doi:10.1016/j.bbcan.2014.08.001

BRIQUET, A., GREGOIRE, C., Comblain, F., Servais, L., Zeddou, M., LECHANTEUR, C., & Beguin, Y. (2014). Human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Ry(null) mice. Cytotherapy, 16, 1511-1518. doi:10.1016/j.jcyt.2014.07.003

CAERS, J., & BEGUIN, Y. (2014). Le myélome multiple asymptomatique : le paysage thérapeutique change. Oncol. Hematol, 8, 39-45.

CAERS, J., Binsfeld, M., Muller, J., Heusschen, R., & Beguin, Y. (2014). Gammapathie monoclonale de signification indéterminée : information destinée aux médecins référents. Revue Médicale de Liège, 69, 41-46.

Chevallier, P., Labopin, M., Milpied, N., Bilger, K., Socié, G., Yakoub-Agha, I., Michallet, M., Bulabois, C.-E., Maury, S., Beguin, Y., Bay, J.-O., Blaise, D., Maillard, N., Guillerm, G., Daguindeau, E., Raus, N., & Mohty, M. (2014). Outcomes of adults with active or progressive hematological malignancies at time of allogeneic stem cell transplantation : a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 49, 361-365.

Damaj, G., Mohty, M., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., Nguyen, S., Bories, P., Blaise, D., Maillard, N., Rubio, M.-T., Fegueux, N., Cornillon, J., Clavert, A., Huynh, A., Adès, L., Thiébaut-Bertrand, A., Hermine, O., Vigouroux, S., ... Yakoub-Agha, I. (2014). Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation, 20, 1349-1355. doi:10.1016/j.bbmt.2014.05.010

Delforge, M., Selleslag, D., BEGUIN, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'Hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaeke, W., ... Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients wih lower risk myelodysplastic syndromes. Leukemia Research, 38, 557-563.

Duléry, R., Mohty, M., Duhamel, A., Robin, M., BEGUIN, Y., Michallet, M., Vigouroux, S., Lioure, B., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Daguindau, E., Ceballos, P., Clément, L., Dauriac, C., Maillard, N., Legrand, F., ... Yakoub-Agha, I. (2014). Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 20, 646-654. doi:10.1016/j.bbmt.2014.01.016

Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333

LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222

Ludwig, H. P., Aapro, M. S., Bokemeyer, C., Glaspy, J. A., Hedenus, M., Littlewood, T. J., Osterborg, A. C., Rzychon, B., Mitchell, D., & BEGUIN, Y. (2014). A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia. Supportive Care in Cancer, 22, 2197-2206. doi:10.1007/s00520-014-2189-0

MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068

Moors, I., Schoemans, H., Callens, S., Beguin, Y., & Kerre, T. (2014). Vaccination guidelines in hematopoietic transplant patients : recommendations from the BHS Transplant Committee. Belgian Journal of Hematology, 6, 44-54.

VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418

Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003
* These authors have contributed equally to this work.

JASPERS, A., CAERS, J., LE GAC, G., FEREC, C., BEGUIN, Y., & FILLET, G. (February 2013). A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA). British Journal of Haematology, 160 (4), 564-565. doi:10.1111/bjh.12147

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

BRIQUET, A., HALLEUX, A., LECHANTEUR, C., & BEGUIN, Y. (2013). Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells ? Cytotherapy, 15, 1385-1394. doi:10.1016/j.jcyt.2013.06.012

COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422.

De Bock, M., Fillet, M., Hannon, M., Seidel, L., Merville, M.-P., Gothot, A., Beguin, Y., & Baron, F. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE, 8 (2), 55876. doi:10.1371/journal.pone.0055876

HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517.

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y

Janssens, A., Lambert, C., Bries, G., Bosly, A., Selleslag, D., & Beguin, Y. (2013). Primary immune thrombocytopenia in adults. Belgian Journal of Hematology, 4 (1), 2-11.

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013

Otjacques, E., Binsfeld, M., Beguin, Y., Noël, A., Cataldo, D., & CAERS, J. (2013). Aspects biologiques de l'angiogenèse dans le myélome multiple. Oncohématologie, 7 (2), 6-12.

Otjacques, E., Binsfeld, M., Rocks, N., Blacher, S., Vanderkerken, K., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2013). Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors. PLoS ONE, 8 (5), 62818. doi:10.1371/journal.pone.0062818

Park, S., Labopin, M., Yakoub-Agha, I., Delaunay, J., Dhedin, N., Deconinck, E., Michallet, M., Robin, M., De Revel, T., Bernard, M., Vey, N., Lioure, B., Lapusan, S., Tabrizi, R., Bourhis, J.-H., Huynh, A., Beguin, Y., Socié, G., Dreyfus, F., ... Mohty, M. (2013). Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. European Journal of Haematology, 90, 355-364. doi:10.1111/ejh.12073

SERVAIS, S., Beguin, Y., & Baron, F. (2013). Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs, 18 (2), 173-192. doi:10.1517/14728214.2013.798642

SERVAIS, S., WILLEMS, E., Beguin, Y., & Baron, F. (2013). Allogreffe de cellules souches hématopoïétiques chez le patient âgé : jusqu'à quel âge ? Revue Médicale de Liège, 68 (1), 38-43.

Aapro, M. S., Osterborg, A. C., Gascon, P., Ludwig, H. P., & BEGUIN, Y. (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Annals of Oncology, 23, 1954-62.

Aapro, M. S., Österborg, A., Gascon, P., Ludwig, H., & Beguin, Y. (2012). Anaemia and cancer : oral or intravenous iron ? Therapeutics, 46-48.

Belle, L., Bruck, F., FOGUENNE, J., GOTHOT, A., BEGUIN, Y., Baron, F., & Briquet, A. (2012). Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34+ Cells. PLoS ONE, 7 (12), 52564. doi:10.1371/journal.pone.0052564

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.

Damaj, G., Duhamel, A., Robin, M., Beguin, Y., Michallet, M., Mohty, M., Vigouroux, S., Bories, P., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Legrand, F., Deconinck, E., Fegueux, N., Clement, L., Dauriac, C., Maillard, N., ... Yakoub-Agha, I. (2012). Impact of Azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes : a study b the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe Francophone des Myélodysplasies. Journal of Clinical Oncology, 30, 4533-4540. doi:10.1200/JCO.2012.44.3499

FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693

Huybrechts, S., BEGUIN, Y., Bordon, V., DRESSE, M.-F., Dupont, S., Ferster, A., Laureys, G., Meyts, I., Renard, M., & Vermylen, C. (2012). Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence. Belgian Journal of Hematology, 3 (2), 34-40.

Kermani, H., Goffinet, L., Mottet, M., Bodart, G., Morrhaye, G., Dardenne, O., Overbergh, L., Baron, F., Beguin, Y., Geenen, V., & Martens, H. (2012). Expression of growth hormone (GH)/insulin-like growth factor (IGF) axis during Balb/c ontogeny and effects of GH upon ex-vivo T-cell differentiation. Neuroimmunomodulation, 19, 137-147.

Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16.

Roelants, V., DELGAUDINE, M., Walrand, S., Lhommel, R., Beguin, Y., Jamar, F., & Vanoverschelde, J.-L. (2012). Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database. EJNMMI Research, 2, 64-75. doi:10.1186/2191-219X-2-64

VANDAMME, A., Schots, R., & BEGUIN, Y. (2012). Academic clinical trials run by the transplant committee of the Belgian Hematological Society. Belgian Journal of Hematology, 3 (2), 62-67.

Verbeke, N., Beguin, Y., Wildiers, H., Canon, J.-L., Bries, G., Bosly, A., & Van Belle, S. (2012). High prevalence of anaemia and limited use of therapy in cancer patients : a Belgian survey (Anaemia Day 2008). Supportive Care in Cancer, 20, 23-28. doi:10.1007/s00520-010-1045-0

VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397.

Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321

Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (July 2011). Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World Journal of Gastroenterology, 17 (25), 3069-72. doi:10.3748/wjg.v17.i25.3069

Aapro, M. S., Beguin, Y., Birgegard, G., Gascon, P., Hedenus, M., & Osterborg, A. (2011). Too low iron doses and too many dropouts in negative iron trial. Journal of Clinical Oncology, 525-e526. doi:10.1200/JCO.2011.35.3219

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.

CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702

DELGAUDINE, M., Lambermont, B., Lancellotti, P., Roelants, V., Walrand, S., Vanoverschelde, J.-L., Pierard, L., Gothot, A., & Beguin, Y. (2011). Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice. Cytotherapy, 13, 237-247. doi:10.3109/14653249.2010.491820

Otjacques, E., Binsfeld, M., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2011). Biological aspects of angiogenesis in multiple myeloma. International Journal of Hematology, 94 (6), 505-18. doi:10.1007/s12185-011-0963-z

Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., De Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kroger, N., & Rocha, V. (2011). Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT. Leukemia, 25, 75-81. doi:10.1038/leu.2010.219

SERVAIS, S., Baron, F., & Beguin, Y. (2011). Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science, 44, 205-210. doi:10.1016/j.transci.2011.01.019

Servais, S., Beguin, Y., & Baron, F. (2011). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). Belgian Journal of Hematology, 2, 3-9.

Baron, F., & Beguin, Y. (2010). Hematopoietic stem cell transplantation in the treatment strategy of acute leukemia. Belgian Journal of Medical Oncology, 4, 118-123.

Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011

Briquet, A., Dubois, S., Bekaert, S., Dolhet, M., Beguin, Y., & Gothot, A. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID -repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica, 95 (1), 47-56. doi:10.3324/haematol.2009.008524

Delgaudine, M., Gothot, A., & Beguin, Y. (2010). Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction. Cytotherapy, 12 (7), 909-18. doi:10.3109/14653240903580262

Dirix, L., Awada, A., Bron, D., Canon, J.-L., De Grève, J., Humblet, Y., Peeters, M., Van Belle, S., Vansteenkiste, J., Beguin, Y., & Vermorken, J. (2010). Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia. Belgian Journal of Medical Oncology, 4, 57-64.

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.

Roufosse, R., & Beguin, Y. (2010). Observance thérapeutique en hématologie : le cas particulier de la leucémie myéloïde chronique. Revue Médicale de Liège, 65, 409-412.

Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x

Servais, S., Willems, E., Beguin, Y., & Baron, F. (2010). Maladie du greffon contre l'hôte chronique : une prise en charge multidisciplinaire. Revue Médicale de Liège, 65, 81-87.

Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230
* These authors have contributed equally to this work.

Willems, E., Humblet-Baron, S., Dengis, O., Seidel, L., Beguin, Y., & Baron, F. (2010). Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 1442-1448. doi:10.1038/bmt.2009.360

Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M., Gothot, A., Lechanteur, C., & Beguin, Y. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34 (7), 693-701. doi:10.1042/CBI20090414

Avivi, I., Montoto, S., Canals, C., Maertens, J., Al-Ali, H., Mufti, G. J., Finke, J., Schattenberg, A., Fanin, R., Cornelissen, J. J., Vernant, J.-P., Russel, N., Beguin, Y., Thomason, K., Verdonck, L. F., Kobbe, G., Tilly, H., Socié, G., & Sureda, A. (2009). Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma : an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology, 147, 719-728. doi:10.1111/j.1365-2141.2009.07905.x

Beguin, Y. (2009). Utilisation thérapeutique de l'érythropoïétine. Revue du Praticien, 59, 82-83.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8.

Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369.

Foguenne, J., Di Stefano, Giet, O., Beguin, Y., & Gothot, A. (2009). Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica, 94, 185-194. doi:10.3324/haematol.13206

Hafraoui, K., Beguin, Y., & Baron, F. (2009). Cancers secondaires après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (10), 496-499.

Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668

Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248
* These authors have contributed equally to this work.

Willems, E., Canivet, J.-L., Ghaye, B., de Leval, L., Radermecker, M., Preiser, J.-C., & Beguin, Y. (2009). Pulmonary veno-occlusive disease in myeloproliferative disorder. European Respiratory Journal, 33 (1), 213-216. doi:10.1183/09031936.00157707

Willemze, R., Rodrigues, C. A., Labopin, M., Sanz, G., Michel, G., Socié, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mothy, M., Ribera, J. M., Garnier, F., Garcia, J., Lecchi, L., Kögler, G., Beguin, Y., Navarette, C., Boogaerts, M., ... Rocha, V. (2009). KIR-ligand incompatibility in the Graft-versus-host direction improves outcome after umbilical cord blood transplantation for acute leukemia. Leukemia, 23, 492-500. doi:10.1038/leu.2008.365

Beguin, Y. (2008). Le sang de cordon ombilical. Revue du Praticien, 58, 2107-08.

Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x

Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708
* These authors have contributed equally to this work.

Hoyoux, C., Dresse, M.-F., Robinet, S., Forget, P., Pieltain, C., Ketelslegers, O., & Beguin, Y. (2008). Cord blood transplantation in a child with Pearson's disease. Pediatric Blood and Cancer, 51 (4), 566. doi:10.1002/pbc.21615

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.

Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8.

Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9.

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Baron, F., Vanstraelen, G., & Beguin, Y. (2006). Transfusions after nonmyeloablative or reduced-intensity conditioning regimens. Leukemia, 20 (12), 2081-6. doi:10.1038/sj.leu.2404431

Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x

Cavill, I., Auerbach, M., Bailie, G. R., Barrett-Lee, P., Beguin, Y., Kaltwasser, P., Littlewood, T., Macdougall, I. C., & Wilson, K. (2006). Iron and the anaemia of chronic disease: a review and strategic recommendations. Current Medical Research and Opinion, 22 (4), 731-7. doi:10.1185/030079906X100096

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255

Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x

Jerusalem, G., & Beguin, Y. (2006). The place of positron emission tomography imaging in the management of patients with malignant lymphoma. Haematologica, 91 (4), 442-4.

Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290
* These authors have contributed equally to this work.

Van Overstraeten-Schlogel, N., Beguin, Y., & Gothot, A. (2006). Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. European Journal of Haematology, 76 (6), 488-93. doi:10.1111/j.1600-0609.2006.00633.x

Van Overstraeten-Schlogel, N., Delgaudine, M., Beguin, Y., & Gothot, A. (2006). Limitations of the use of GFP transgenic mice in bone marrow transplantation studies. Leukemia and Lymphoma, 47 (7), 1392-3. doi:10.1080/10428190500513512

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012

Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013

Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017

Beguin, Y. (2005). Intravenous iron and recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology, 23 (3), 651-2; author reply 652-3. doi:10.1200/JCO.2005.05.184

Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51.

Foguenne, J., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2005). Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion. Haematologica, 90 (4), 445-51.

Glaspy, J., & Beguin, Y. (2005). Anaemia management strategies: optimising treatment using epoetin beta (NeoRecormon). Oncology, 69 Suppl 2, 8-16. doi:10.1159/000088283

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004

Piette, C., Dresse, M.-F., Forget, P., Schmitz, V., Demarche, M., Erpicum, P., Closon, M.-T., Rutten, I., Paulus, P., Vivegnis, D., Beguin, Y., Jamblin, P., & Hoyoux, C. (2005). Les neuroblastomes de l'enfant. A propos de 23 cas. Revue Médicale de Liège, 60 (3), 173-80.

T'Sjoen, G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J.-M., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186 (1), 61-7. doi:10.1677/joe.1.06112

Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70.

Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7.

Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8.

Beguin, Y., & Weber, G. (2004). Serum selenium in lymphoma. Journal of Clinical Oncology, 22 (16), 3429; author reply 3430. doi:10.1200/JCO.2004.99.240

Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9.

Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414

Passweg, J. R., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, Pilatrino, C., Quartier, P., Stary, J., Veys, P., ... Gratwohl, A. (2004). Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. British Journal of Haematology, 125 (6), 749-55. doi:10.1111/j.1365-2141.2004.04978.x

Willems, E., Valdes Socin, H. G., Betea, D., Beckers, A., & Beguin, Y. (September 2003). Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds. Leukemia, 17 (9), 1912-1914. doi:10.1038/sj.leu.2403064

Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220

Baron, F., DRESSE, M.-F., & Beguin, Y. (2003). Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. New England Journal of Medicine, 349 (9), 913-4. doi:10.1056/NEJM200308283490921

Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80.

Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7.

Baron, F., Frere, P., & Beguin, Y. (2003). Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Haematologica, 88 (6), 718-20.

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72.

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Beguin, Y. (2003). Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clinica Chimica Acta, 329 (1-2), 9-22. doi:10.1016/S0009-8981(03)00005-6

Beguin, Y., & Baron, F. (2003). Minitransplants: allogeneic stem cell transplantation with reduced toxicity. Acta Clinica Belgica, 58 (1), 37-45. doi:10.1179/acb.2003.58.1.005

Canivet, J.-L., Yans, T., Piret, S., Frere, P., & Beguin, Y. (2003). Barotrauma-induced tension pneumoperitoneum. Acta Anaesthesiologica Belgica, 54 (3), 233-6.

Cazzola, M., Beguin, Y., Kloczko, J., Spicka, I., & Coiffier, B. (2003). Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. British Journal of Haematology, 122 (3), 386-93. doi:10.1046/j.1365-2141.2003.04439.x

Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2003). Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells. Leukemia and Lymphoma, 44 (8), 1379-83. doi:10.1080/1042819031000083406

Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12.

Humblet-Baron, S., Baron, F., Chachati, A., Bury, J., Morelon, E., Kreis, H., & BEGUIN, Y. (2003). Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation, 76 (10), 1531-2. doi:10.1097/01.TP.0000085285.59061.D7

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5

Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Beguin, Y., Brunet, S., Caballero, D., Majolino, I., Hagberg, H., Johnsen, H. E., Kimby, E., Montserrat, E., Stewart, D., Copplestone, A., Rosler, W., Pavel, J., Kingreen, D., & Siegert, W. (2003). Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88 (11), 1272-8.

Humblet-Baron, S., Baron, F., Pirson, L., Beguin, Y., & Fillet, G. (28 August 2002). Traitement moléculaire du cancer: le STI571, un inhibiteur des tyrosines kinases. Revue Médicale Suisse, 60 (598), 1504-1508.

Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484

Baron, F., & Beguin, Y. (2002). Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8 (7), 351-9. doi:10.1053/bbmt.2002.v8.pm12171481

Baron, F., & Beguin, Y. (2002). Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11 (2), 243-63. doi:10.1089/152581602753658448

Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008

Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43.

Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6

Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88.

Beguin, Y. (2002). Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients. Haematologica, 87 (11), 1209-21.

Beguin, Y. (2002). Le métabolisme du fer. Hématologie, 8, 7-S11.

Beguin, Y., Benoit, Y., Crokaert, F., Selleslag, D., & Vandercam, B. (2002). Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel. Acta Clinica Belgica, 57 (6), 309-16. doi:10.1179/acb.2002.058

Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x

Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413

Giet, O., Van Bockstaele, D. R., Di Stefano, I., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2002). Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood, 99 (6), 2023-31. doi:10.1182/blood.V99.6.2023

Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2002). Modulation par le cycle cellulaire de l'implantation des cellules souches hématopoïétiques. Hématologie, 8, 397-404.

Huygen, S., Giet, O., Artisien, V., Di Stefano, I., Beguin, Y., & Gothot, A. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood, 100 (8), 2744-52. doi:10.1182/blood.V100.8.2744

Jerusalem, G., & Beguin, Y. (2002). Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clinical Lymphoma, 3 (1), 56-61. doi:10.3816/CLM.2002.n.012

Jerusalem, G., & Beguin, Y. (2002). Does positron emission tomography have a role in routine clinical practice in patients with Hodgkin's disease? Clinical Lymphoma, 3 (2), 125-6. doi:10.1016/S1526-9655(11)70258-5

Jerusalem, G., & Beguin, Y. (2002). Commentary on "Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?". Clinical Lymphoma, 2 (4), 249. doi:10.1016/S1526-9655(11)70232-9

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664

Verhoef, H., West, C. E., Veenemans, J., Beguin, Y., & Kok, F. J. (2002). Stunting may determine the severity of malaria-associated anemia in African children. Pediatrics, 110 (4), 48. doi:10.1542/peds.110.4.e48

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.

Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4.

Beguin, Y. (2001). Intérêt du dosage du récepteur soluble de la transferrine (sTfR) pour l'évaluation de l'érythropoïèse et de l'état du fer. Hématologie, 7, 161-169.

Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024

Giet, O., Huygen, S., Beguin, Y., & Gothot, A. (2001). Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Experimental Hematology, 29 (4), 515-24. doi:10.1016/S0301-472X(00)00682-2

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73.

Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.

Paquet, P., Arrese Estrada, J., Beguin, Y., & Pierard, G. (2001). Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. Current Topics in Pathology. Ergebnisse der Pathologie, 94, 49-63. doi:10.1007/978-3-642-59552-3_3

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442

R'Zik, S., & Beguin, Y. (2001). Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Experimental Hematology, 29 (6), 677-85. doi:10.1016/S0301-472X(01)00641-5

R'Zik, S., Loo, M., & Beguin, Y. (2001). Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica, 86 (3), 244-51.

Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18.

Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609.

Verhoef, H., West, C. E., Ndeto, P., Burema, J., Beguin, Y., & Kok, F. J. (2001). Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. American Journal of Clinical Nutrition, 74 (6), 767-75. doi:10.1093/ajcn/74.6.767

JERUSALEM, G., & BEGUIN, Y. (June 2000). Commentary on "Positron emission tomography in lymphoma : comparison with computed tomography and Gallium-67 single photon emission computed tomography imaging". Clinical Lymphoma, 1 (1), 75-76.

Baron, F., & Beguin, Y. (2000). Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion, 40 (4), 468-76. doi:10.1046/j.1537-2995.2000.40040468.x

Baron, F., Dresse, M.-F., & Beguin, Y. (2000). Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease. Transfusion, 40 (9), 1071-3. doi:10.1046/j.1537-2995.2000.40091071.x

Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x

Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x

Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x

Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x

Jerusalem, G., & Beguin, Y. (2000). Clinical impact and perspectives of 18F-FDG PET in lymphoma. Clinical Lymphoma, 1, 75-76.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8.

Magee, L. A., von Dadelszen, P., Darley, J., & Beguin, Y. (2000). Erythropoiesis and renal transplant pregnancy. Clinical Transplantation, 14 (2), 127-35. doi:10.1034/j.1399-0012.2000.140205.x

Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x

Roodenburg, A. J., West, C. E., Beguin, Y., Van Dijk, J. E., Van Eijk, H. G., Marx, J. J., & Beynen, A. C. (2000). Indicators of erythrocyte formation and degradation in rats with either vitamin A or iron deficiency. Journal of Nutritional Biochemistry, 11 (4), 223-30. doi:10.1016/S0955-2863(00)00070-X

Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634.

Tassin, F., Dewé, W., Schaaf-Lafontaine, N., Herens, C., Ravoet, C., Albert, A., Beguin, Y., & Paulus, J.-M. (2000). A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes. Leukemia and Lymphoma, 36 (5-6), 485-96. doi:10.3109/10428190009148396

Beguin, Y. (1999). Erythropoietin and platelet production. Haematologica, 84 (6), 541-7.

Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y., Albert, A., & Paulus, J.-M. (1999). Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International, 56 (3), 1113-9. doi:10.1046/j.1523-1755.1999.00627.x

Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A., & Galanello, R. (1999). Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. British Journal of Haematology, 106 (3), 752-5. doi:10.1046/j.1365-2141.1999.01600.x

Cornu, G., Vermylen, C., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1999). La greffe de cellules souches hematopoietiques dans la drepanocytose. Archives de Pédiatrie, 6 Suppl 2, 345s-347. doi:10.1016/s0929-693x(99)80463-1

Dresse, M.-F., Boogaerts, M., Vermylen, C., Noens, L., Ferrant, A., Schots, R., Doyen, C., Bron, D., Berneman, Z., Ferster, A., Benoit, Y., Demuynck, H., & Beguin, Y. (1999). The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica, 84 (7), 637-42.

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433

Loo, M., & Beguin, Y. (1999). The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood, 93 (10), 3286-93. doi:10.1182/blood.v93.10.3286.410k29_3286_3293

Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x

Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9.

Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198

Baron, F., Hermanne, J. P., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1998). Le cas clinique du mois. Association d'une maladie de Hodgkin et d'un syndrome nephrotique. Revue Médicale de Liège, 53 (11), 651-3.

Baron, F., Sadzot, B., Wang, F.-C., & Beguin, Y. (1998). Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 22 (2), 197-200. doi:10.1038/sj.bmt.1701297

Baudoux, E., Beguin, Y., Cornu, G., Brichard, B., Debruyn, C., De Bruyere, M., De Hemptinne, D., Delforge, A., Deneys, V., Fillet, G., Germeau, N., Joris, I., Lefevre, P., Massy, M., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Sondag, D., Van Cauwenberge, J.-R., ... Strijckmans, P. (1998). Circadian and seasonal variations of hematopoiesis in cord blood. Bone Marrow Transplantation, 22 Suppl 1, 12.

Beguin, Y. (1998). Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer. Medical Oncology, 15 Suppl 1, 38-46.

Beguin, Y. (1998). Prediction of response to optimize outcome of treatment with erythropoietin. Seminars in Oncology, 25 (3 Suppl 7), 27-34.

Beguin, Y. (1998). A risk-benefit assessment of epoetin in the management of anaemia associated with cancer. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 19 (4), 269-82. doi:10.2165/00002018-199819040-00003

Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81.

Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x

Cazzola, M., Guarnone, R., Cerani, P., Centenara, E., Rovati, A., & Beguin, Y. (1998). Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood, 91 (6), 2139-45. doi:10.1182/blood.v91.6.2139.2139_2139_2145

Corazza, F., Beguin, Y., Bergmann, P., Andre, M.-E., Ferster, A., Devalck, C., Fondu, P., Buyse, M., & Sariban, E. (1998). Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood, 92 (5), 1793-8. doi:10.1182/blood.v92.5.1793.417k23_1793_1798

Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J. M., Winqvist, I., Oberg, G., Osterborg, A., & Ost, A. (1998). Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92 (1), 68-75. doi:10.1182/blood.v92.1.68.413k23_68_75

Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142.

van Iperen, C. E., Kraaijenhagen, R. J., Biesma, D. H., Beguin, Y., Marx, J. J., & van de Wiel, A. (1998). Iron metabolism and erythropoiesis after surgery. British Journal of Surgery, 85 (1), 41-5. doi:10.1046/j.1365-2168.1998.00571.x

Vermylen, C., Cornu, G., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1998). Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation, 22 (1), 1-6. doi:10.1038/sj.bmt.1701291

Baron, F., & Beguin, Y. (1997). Complications hepatiques de la chimiotherapie. De la cytolyse banale a la maladie veino-occlusive du foie. Revue Médicale de Liège, 52 (2), 93-7.

Baron, F., & Beguin, Y. (1997). Complications hépatiques de la chimiothérapie : de la cytolyse banale à la maladie veino-occlusive du foie. Médecine and Chirurgie Digestives, 26, 269-272.

Baron, F., Deprez, M., & Beguin, Y. (1997). The veno-occlusive disease of the liver. Haematologica, 82 (6), 718-25.

Beguin, Y. (1997). Mechanisms of cancer-related anemia and rationale for erythropoietin treatment. Cancer Biotherapy, 1, 88-96.

Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75

Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z

Cavill, I., Macdougall, I. C., Gokal, R., Beguin, Y., Peters, T. J., Pippard, M., Schaefer, R. M., & Winearls, C. G. (1997). Iron management in patients on rHuEpo. British Journal of Renal Medicine, 2, 6-8.

Cazzola, M., Borgna-Pignatti, C., Locatelli, F., Ponchio, L., Beguin, Y., & De Stefano, P. (1997). A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion, 37 (2), 135-40. doi:10.1046/j.1537-2995.1997.37297203514.x

Dowlati, A., Loo, Bury, T., Fillet, G., & Beguin, Y. (1997). Soluble and cell-associated transferrin receptor in lung cancer. British Journal of Cancer, 75 (12), 1802-6. doi:10.1038/bjc.1997.307

Dowlati, A., R'Zik, S., Fillet, G., & Beguin, Y. (1997). Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production. British Journal of Haematology, 97 (2), 297-9. doi:10.1046/j.1365-2141.1997.472694.x

Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8.

Beguin, Y. (1996). La greffe de cellules souches hematopoietiques (greffe de moelle osseuse"): indications, modalites et risques.". Revue Médicale de Liège, 51 (4), 270-5.

Beguin, Y. (1996). Erythropoietin and the anemia of cancer. Acta Clinica Belgica, 51 (1), 36-52. doi:10.1080/17843286.1996.11718483

Beguin, Y., Collignon, J., Laurent, C., & Fillet, G. (1996). Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome. British Journal of Haematology, 94 (3), 507-9. doi:10.1046/j.1365-2141.1996.d01-1824.x

Beguin, Y., Lampertz, S., Bron, D., & Fillet, G. (1996). Serum erythropoietin in chronic lymphocytic leukaemia. British Journal of Haematology, 93 (1), 154-6. doi:10.1046/j.1365-2141.1996.452992.x

Cazzola, M., Ponchio, L., de Benedetti, F., Ravelli, A., Rosti, V., Beguin, Y., Invernizzi, R., Barosi, G., & Martini, A. (1996). Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood, 87 (11), 4824-30. doi:10.1182/blood.v87.11.4824.bloodjournal87114824

Cazzola, M., Ponchio, L., Pedrotti, C., Farina, G., Cerani, P., Lucotti, C., Novella, A., Rovati, A., Bergamaschi, G., & Beguin, Y. (1996). Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica, 81 (5), 434-41.

Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489.

Pasquasy, V., Delvenne, P., Thiry, A., Beguin, Y., & Boniver, J. (1996). Confrontation anatomo-clinique. Purpura thrombocytopenique thrombotique dans le decours d'une greffe de moelle. Revue Médicale de Liège, 51 (11), 714-7.

Beguin, Y. (1995). Pharma clinics. Comment je traite ... une anemie (3e partie). Revue Médicale de Liège, 50 (12), 497-8.

Beguin, Y. (1995). Erythropoiesis and erythropoietin in multiple myeloma. Leukemia and Lymphoma, 18 (5-6), 413-21. doi:10.3109/10428199509059639

Beguin, Y. (1995). Comment j'explore ... une anemie (2eme partie). Revue Médicale de Liège, 50 (11), 487-8.

Beguin, Y. (1995). Comment j'explore... Une anemie (1e partie). Revue Médicale de Liège, 50 (10), 443-4.

Beguin, Y. (1995). Biology and clinical uses of erythropoietin in infants and children. International Journal of Pediatric Hematology/Oncology, 2, 457-470.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1995). Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. British Journal of Haematology, 89 (1), 17-23. doi:10.1111/j.1365-2141.1995.tb08916.x

Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1995). Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. European Journal of Clinical Investigation, 25 (6), 383-9. doi:10.1111/j.1365-2362.1995.tb01718.x

Cazzola, M., De Stefano, P., Ponchio, L., Locatelli, F., Beguin, Y., Dessi, C., Barella, S., Cao, A., & Galanello, R. (1995). Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. British Journal of Haematology, 89 (3), 473-8. doi:10.1111/j.1365-2141.1995.tb08351.x

Danielson, B., Beguin, Y., Bommer, J., Cannata, B., De Broe, M.-E., Drüeke, T. B., Ittel, T. H., Jolliffe, L. K., Krantz, S. B., Nielsen, O. J., Pippard, M. J., Rosenlöf, K., Stockenhuber, B., & Winearls, C. G. (1995). R-HuEPO hyporesponsiveness - who and why ? Nephrology Dialysis Transplantation, 10, 69-76. doi:10.1093/ndt/10.supp2.69

Davies, S. V., Fegan, C. D., Kendall, R., Beguin, Y., & Cavill, I. (1995). Serum erythropoietin during autologous bone marrow transplantation: relationship to measures of erythroid activity. Clinical and Laboratory Haematology, 17 (2), 139-44.

Dowlati, A., Honore, P., Damas, P., Deprez, M., Delwaide, J., Fillet, G., & Beguin, Y. (1995). Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation, 60 (1), 106-9. doi:10.1097/00007890-199507150-00020

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1994). Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. European Journal of Haematology, 53 (5), 265-70. doi:10.1111/j.1600-0609.1994.tb01318.x

Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1994). Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. European Journal of Clinical Investigation, 24 (6), 426-32. doi:10.1111/j.1365-2362.1994.tb02187.x

Bowen, D. T., Culligan, D., Beguin, Y., Kendall, R., & Willis, N. (1994). Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia, 8 (1), 151-5.

Fraipont, V., Beguin, Y., & Fillet, G. (1994). L'anemie ferriprive de la grossesse. Revue Médicale de Liège, 49 (8), 436-45.

Locatelli, F., Zecca, M., Pedrazzoli, P., Prete, L., Quaglini, S., Comoli, P., De Stefano, P., Beguin, Y., Robustelli della Cuna, G., Severi, F., & Cazzola, M. (1994). Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplantation, 13 (4), 403-10.

Locatelli, F., Zecca, M., Ponchio, L., Beguin, Y., Giorgiani, G., Maccario, R., Bonetti, F., De Stefano, P., & Cazzola, M. (1994). Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation, 14 (6), 929-35.

Martelli, M., Ponchio, L., Beguin, Y., Meloni, G., Mandelli, F., & Cazzola, M. (1994). Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica, 79 (5), 456-9.

Beguin, Y. (1993). Mesures quantitatives de l'erythropoiese. Le recepteur soluble de la transferrine. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 148 (1-2), 100-4; discussion 105-7.

Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067

Beguin, Y., Lampertz, S., De Groote, D., Igot, D., Malaise, M., & Fillet, G. (1993). Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia, 7 (12), 2019-2025.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1993). Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood, 82 (7), 2010-6. doi:10.1182/blood.v82.7.2010.bloodjournal8272010

Beguin, Y., Oris, R., & Fillet, G. (1993). Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplantation, 11 (4), 285-92.

Feron, C., Gothot, A., Grosdent, J.-C., Van Cauwenberge, J.-R., Schaaps, J.-P., Beguin, Y., & Paulus, J.-M. (1993). Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results. Journal of Hematotherapy, 2 (2), 259-61. doi:10.1089/scd.1.1993.2.259

Locatelli, F., Zecca, M., Beguin, Y., Giorgiani, G., Ponchio, L., De Stefano, P., & Cazzola, M. (1993). Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. British Journal of Haematology, 84 (4), 752-4. doi:10.1111/j.1365-2141.1993.tb03158.x

Antoine, N., Beckers, C., Marcoty, C., Bosseloir, A., Beguin, Y., Schaaf-Lafontaine, N., & Simar, L. J. (1992). Expression de l'antigene DRC1 par les cellules leucemiques. Revue Médicale de Liège, 47 (2), 95-9.

Beguin, Y. (1992). The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis. Haematologica, 77 (1), 1-10.

Beguin, Y., Yerna, M., Loo, M., Weber, M., & Fillet, G. (1992). Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. British Journal of Haematology, 82 (4), 648-53. doi:10.1111/j.1365-2141.1992.tb06939.x

Cazzola, M., & Beguin, Y. (1992). Serum erythropoietin levels during haematinic treatment. British Journal of Haematology, 82, 631-632.

Cazzola, M., & Beguin, Y. (1992). New tools for clinical evaluation of erythron function in man. British Journal of Haematology, 80 (3), 278-84. doi:10.1111/j.1365-2141.1992.tb08133.x

Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N. L., Fregoni, V., Nalli, G., Barosi, G., & Ascari, E. (1992). Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79 (1), 29-37. doi:10.1182/blood.v79.1.29.bloodjournal79129

De Groote, D., Zangerlé, P.-F., Gevaert, Y., Fassotte, M.-F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez Y Cadenas, M., & Dehart, I. (1992). Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine, 4 (3), 239-48. doi:10.1016/1043-4666(92)90062-V

Elira-Dokekias, A., R'Zik, S., Beguin, Y., & Fillet, G. (1992). Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin. Nouvelle Revue Française d'Hématologie, 34 (3), 257-8.

Ponchio, L., Beguin, Y., Farina, G., Pedrazzoli, P., Pedrotti, C., Poggi, G., Rosti, V., Bergamaschi, G., Battistel, V., & Cazzola, M. (1992). Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. Haematologica, 77 (6), 494-501.

Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868

Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89

Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045.

Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045.

Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N

Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79.

Beguin, Y., & Fillet, G. (1990). Erythropoietine: utilisation diagnostique et therapeutique. Revue Médicale de Liège, 45 (6), 261-7.

Beguin, Y., Lipscei, G., Oris, R., Thoumsin, H., & Fillet, G. (1990). Serum immunoreactive erythropoietin during pregnancy and in the early postpartum. British Journal of Haematology, 76 (4), 545-9. doi:10.1111/j.1365-2141.1990.tb07914.x

Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671.

Huebers, H. A., Beguin, Y., Pootrakul, P., Einspahr, D., & Finch, C. A. (1990). Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood, 75 (1), 102-7. doi:10.1182/blood.v75.1.102.102

Beguin, Y., Bours, V., Delbrouck, J. M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (November 1989). Relationship of Serum Selenium Levels to Tumor Activity in Acute Non-Lymphocytic Leukemia. Carcinogenesis, 10 (11), 2089-91. doi:10.1093/carcin/10.11.2089

Beguin, Y., Fillet, G., Bury, J., & Fairon, Y. (1989). Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis. American Journal of Hematology, 32 (2), 123-8. doi:10.1002/ajh.2830320209

Beguin, Y., Huebers, H. A., Weber, G., Englebert, M., & Finch, C. A. (1989). Hepatocyte iron release in rats. Journal of Laboratory and Clinical Medicine, 113 (3), 346-54.

Defraigne, J.-O., Closon, M.-T., Bruyninx, L., Dewandre, J., Hourlay, P., Meurisse, M., Honore, P., Bury, J., & Beguin, Y. (1989). Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases. European Journal of Surgical Oncology, 15 (1), 61-4.

Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844

Fillet, G., & Beguin, Y. (1989). Reutilisation du fer dans l'organisme et regulation du fer de reserve. Interet du dosage du recepteur de la transferrine dans le plasma. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 144 (1-2), 113-8; discussion 118-20.

Grek, V., Hay, F., Beguin, Y., Andrien, F., Dokekias, A., & Fillet, G. (1989). La leucémie a tricholeucocyte: 30 ans après. Revue Médicale de Liège, 44 (10), 358-64.

Beguin, Y., Bergamaschi, G., Huebers, H. A., & Finch, C. A. (1988). The behavior of asialotransferrin-iron in the rat. American Journal of Hematology, 29 (4), 204-10. doi:10.1002/ajh.2830290406

Beguin, Y., & Fillet, G. (1988). Les états de surcharge en fer: hémosiderose et hémochromatose. Revue Médicale de Liège, 43 (8), 275-82.

Beguin, Y., Huebers, H., & Finch, C. A. (1988). Random distribution of iron among the two binding sites of transferrin in patients with various hematologic disorders. Clinica Chimica Acta, 173 (3), 299-304. doi:10.1016/0009-8981(88)90017-4

Beguin, Y., Huebers, H. A., Josephson, B., & Finch, C. A. (1988). Transferrin receptors in rat plasma. Proceedings of the National Academy of Sciences of the United States of America, 85 (2), 637-40. doi:10.1073/pnas.85.2.637

Beguin, Y., Stray, S. M., Cazzola, M., Huebers, H. A., & Finch, C. A. (1988). Ferrokinetic measurement of erythropoiesis. Acta Haematologica, 79 (3), 121-6. doi:10.1159/000205743

Beguin, Y., Boniver, J., Bury, J., Defraigne, J.-O., Detroz, B., Fillet, G., & Lejeune, G. (1987). Plasmacytoma of the thyroid: a case report, a study with use of the immunoperoxidase technique, and a review of the literature. Surgery, 101 (4), 496-500.

Beguin, Y., Brasseur, F., Weber, G., Bury, J., Delbrouck, J.-M., Roelandts, I., Robaye, G., & Fillet, G. (1987). Observations of serum trace elements in chronic lymphocytic leukemia. Cancer, 60 (8), 1842-6. doi:10.1002/1097-0142(19871015)60:8<1842::AID-CNCR2820600828>3.0.CO;2-W

Beguin, Y., Bury, J., Delbrouck, J. M., Fillet, G., Robaye, G., Roelandts, I., & Weber, G. (1987). Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia. Haematology and Blood Transfusion, 30, 380-4. doi:10.1007/978-3-642-71213-5_64

Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545.

Bury, J., Andrien, F., Baudrihaye, M., Beguin, Y., Duvivier, A., Hoyoux, C., Runde, V., & Fillet, G. (1987). Greffe de moelle: résultats préliminaires au CHU. Revue Médicale de Liège, 42 (10), 510-5.

Fillet, G., Bury, J., Beguin, Y., Duvivier, A., Hoyoux, C., & Bours, V. (1987). Les cancers hématologiques en 1987. Chimiothérapie et immunothérapie. Revue Médicale de Liège, 42 (10), 496-502.

Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887.

Beguin, Y., Weber, G., Delbrouck, J. M., Roelandts, I., Robaye, G., Bury, J., & Fillet, G. (1986). Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacologica et Toxicologica, 59 Suppl 7, 270-3. doi:10.1111/j.1600-0773.1986.tb02760.x

Beguin, Y., Bury, J., Fillet, G., & Lennes. (1985). Treatment of acute nonlymphocytic leukemia in young and elderly patients. Cancer, 56 (11), 2587-92. doi:10.1002/1097-0142(19851201)56:11<2587::AID-CNCR2820561109>3.0.CO;2-8

Weber, G., Robaye, G., BARTSCH, P., Collignon, A., Beguin, Y., Roelandts, I., & Delbrouck, J.-M. (1984). Trace element analysis by PIXE in several biomedical fields. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B3, 326-331. doi:10.1016/0168-583X(84)90388-4

Articles accepted in journal without reviewing

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Baron, F., & Beguin, Y. (2010). GVHD chronique et effet anti-tumoral. Correspondance en Onco-Hématologie, 5, 12-16.

Dresse, M.-F., & Beguin, Y. (2007). Haematopoietic stem cell transplantation for children in Belgium. Tijdschrift van de Belgische Kinderarts, 1, 44-51.

Hermanne, J.-P., & Beguin, Y. (1997). Use of recombinant human erythropoietin after allogeneic bone marrow transplantation. Erythropoiesis, 8, 80-83.

Beguin, Y. (1994). Greffes de moelle dans les hémoglobinopathies. Mini Acta, 26, 249-250.

Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464.

Beguin, Y. (1993). Contribution of the soluble transferrin receptor to the quantitative evaluation of erythroid marrow function. Erythropoiesis, 4, 99-109.

Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168.

Articles accepted in conference proceedings

VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45.

Ritacco, C., Ehx, G., Canti, L., DUBOIS, S., Vandenhove, B., SERVAIS, S., Beguin, Y., & Baron, F. (01 March 2020). Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects. Biology of Blood and Marrow Transplantation, 26 (3), 168. doi:10.1016/j.bbmt.2019.12.028

VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051.

Ehx, G., Hannon, M., DUBOIS, S., Daulne, C., Drion, P., BEGUIN, Y., Humblet-Baron, S., & BARON, F. (March 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Biology of Blood and Marrow Transplantation, 23 (3), 365–S366. doi:10.1016/j.bbmt.2016.12.314

Ehx, G., HANNON, M., Dubois, S., Daulne, C., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (10 February 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Journal of Clinical Immunology, 37 (2), 197-266. doi:10.1007/s10875-017-0372-z

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12.

Farhat, K., Bodart, G., Martens, H., Baron, F., Beguin, Y., Moutschen, M., Salvatori, R., & Geenen, V. (2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Neuroimmunomodulation.

HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002

Ehx, G., Fransolet, G., de Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (March 2016). Azacytidine Enhances Regulatory T-Cells In Vivo and Prevents Experimental Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation, 22 (3), 393. doi:10.1016/j.bbmt.2015.11.917

Heusschen, R., Muller, J., Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2016). SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma. Belgian Journal of Hematology.

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.

Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27.

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052.

DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29.

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.

Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood.

Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood, 126 (23), 3018.

Muller, J., Binsfeld, M., DUBOIS, S., Carmeliet, G., Beguin, Y., Heusschen, R., & CAERS, J. (2015). The anti-angiogenic peptide Anginex blocks osteoclastogenesis. Belgian Journal of Hematology, Abstracts book.

BEGUIN, Y., ZACHEE, P., MAERTENS, J., KERRE, T., ORY, A., SEIDEL, L., GRAUX, C., LEWALLE, P., VAN GELDER, M., THEUNISSEN, K., WILLEMS, E., EMONDS, M.-P., DE BECKER, A., & BARON, F. (December 2014). Nonmyeloablative allogeneic hematopoietic cell transplantation following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Blood, 124 (21), 542.

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

VALDES SOCIN, H. G., Potorac, I., DE PASQUAL, A., BARON, F., DE PRIJCK, B., Beguin, Y., & Beckers, A. (2014). Leucémie myéloblastique aiguë : sécrétion paranéoplasique de GH et de PRL ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Françaose d'Endocrinologie, Lyon 5-8 novembre 2014.

Binsfeld, M., BEGUIN, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Drion, P., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. Belgian Journal of Hematology.

Binsfeld, M., Heusschen, R., Lamour, V., Van Valckenborgh, E., Bellahcene, A., Baron, F., BEGUIN, Y., & CAERS, J. (2014). Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines. Belgian Journal of Hematology.

Heusschen, R., Schulkens, I., Muller, J., Griffoen, A., Beguin, Y., Thijssen, V., & CAERS, J. (2014). Galectins in cancer: jacks of all trades. International Journal of Molecular Medicine.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14.

Muller, J., CAERS, J., Binsfeld, M., Dubois, S., Carmeliet, G., BEGUIN, Y., & Heusschen, R. (2014). Galectin expression in the multiple myeloma microenvironment. Belgian Journal of Hematology.

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.

Belle, L., Ehx, G., SOMJA, J., BINSFELD, M., Hannon, M., Caers, J., Fransolet, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (December 2013). Combination Of Regulatory T Cells and Rapamycin As Treatment For Experimental Chronic Graft-Versus-Host Disease. Blood, 122 (21), 4474.

Belle, L., BINSFELD, M., DUBOIS, S., Hannon, M., Caers, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (February 2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin. Biology of Blood and Marrow Transplantation, 19, 317.

Belle, L., Binsfeld, M., HANNON, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease. Belgian Journal of Hematology.

Binsfeld, M., Otjacques, E., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & CAERS, J. (2013). The Immunomodulating Peptide Thymosin Alpha 1 Has no Effect on Multiple Myeloma Evolution and on Immune Reconstitution. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 41.

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2013). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 38.

Hannon, M., LECHANTEUR, C., Somja, J., Lucas, S., Belle, L., Bruck, F., Baudoux, E., Beguin, Y., Humblet-Baron, S., & Baron, F. (2013). Infusion of CliniMACS (Myltenyi Biotec) Enriched Regulatory T Cells Delays Experimental Xenogeneic Graft-versus-Host Disease. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 15.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16.

Belle, L., BINSFELD, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humbelt-Baron, S., & BARON, F. (April 2012). Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice. Bone Marrow Transplantation, 47 Suppl 1.

SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (February 2012). Longitudinal Monitoring of Immune Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): Impact of T-Cell Depletion of the Graft. Biology of Blood and Marrow Transplantation, 18 (2), 274-S275. doi:10.1016/j.bbmt.2011.12.193

Belle, L., Bruck, F., FOGUENNE, J., Gothot, A., Beguin, Y., Baron, F., & BRIQUET, A. (2012). Imatinib and Nilotinib do not prevent adhesion and migration of human CD34+ in vitro and in immunodeficient mice. Belgian Journal of Hematology.

Binsfeld, M., Belle, L., Hannon, M., DUBOIS, S., Otjacques, E., Beguin, Y., Baron, F., & CAERS, J. (2012). Adaptation of a Murine Chronic GVH Model to Study Graft versus Myeloma Effect after Allogeneic Transplantation. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16.

Binsfeld, M., Belle, L., Hannon, M., Hofgaard, Dubois, S., Otjacques, E., BEGUIN, Y., Bogen, BARON, F., & CAERS, J. (2012). Adaptation of a murine chronic GvH model to study graftversus- myeloma effect after allogeneic transplantation. Bone Marrow Transplantation, 47 (Suppl.1).

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica, 97 (Supplement 1), 180.

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning? Haematologica, 97 (Supplement 1), 720.

MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). Evidence for Expansion of Host-derived CMV-specific CD8+ T cells after Allogeneic Transplantation with Non-Myeloablative Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16.

Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (February 2011). LIVER TRANSPLANTATION FOR ACUTE HEPATIC FAILURE DUE TO CHEMOTHERAPY-INDUCED HEPATITIS B VIRUS REACTIVATION IN LYMPHOMA PATIENTS. Transplant International, 24 (1), 10-10.

Belle, L., Baron, F., Bruck, F., Hannon, M., SERVAIS, S., Beguin, Y., & BRIQUET, A. (2011). Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice. Belgian Journal of Hematology.

BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510.

Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Daulne, C., Willems, E., Gothot, A., Beguin, Y., & Baron, F. (2011). Comparison of Immune Reconstitution after Non-myeloablative Hematopoietic Cell Transplantation (HCT) with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 8.

SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (2011). Longitudinal Monitoring of Immune Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation (HSCT): Impact of T Cell Depletion of the Graft. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 31.

Humblet-Baron, S., CASTERMANS, E., Vanbellinghen, J.-F., Hannon, M., Jacobs, N., WILLEMS, E., Ormenese, S., Beguin, Y., & Baron, F. (February 2009). What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning? Biology of Blood and Marrow Transplantation, 15 (2), 122-123. doi:10.1016/j.bbmt.2008.12.377

Briquet, A., Dolhet, M., Beguin, Y., & Gothot, A. (2009). Inhibition of the Jagged-1/Notch pathway increases the hematopoiesis-supportive activity of mesenchymal stem cells. Experimental Hematology, 37 (9), 77.

Castermans, E., Hannon, M., Cheynier, R., Seidel, L., Humblet-Baron, S., WILLEMS, E., Corbier, S., Gothot, A., Geenen, V., Sandmaier, B. M., Storb, R. F., Beguin, Y., & Baron, F. (2009). Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age. Blood, 114 (22), 1149.

Humblet-Baron, S., CASTERMANS, E., Vanbellighen, J.-F., Hannon, M., Jacobs, N., Beguin, Y., & Baron, F. (February 2008). What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 14 (2), 136-137. doi:10.1016/j.bbmt.2007.12.383

Briquet, A., Beguin, Y., & Gothot, A. (September 2007). The hematopoiesis-supporting activity of mesenchymal stem cells increases with the number of passages. Experimental Hematology, 35 (9, Suppl. 2), 125-125.

Briquet, A., Dolhet, M., Demeuse, J., BEGUIN, Y., & GOTHOT, A. (August 2007). Study of contribution of signalling pathways Notch, Wnt, Shh and BMP in mesenchymal stem cell prohaematopoietic activity. Acta Clinica Belgica, 62 (4), 256.

Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439.

Castermans, E., Baron, F., Willems, E., Meuris, N., Schaaf-Lafontaine, N., Reynier, R., Geenen, V., & Beguin, Y. (2006). Immune reconstitution after CD8-depleted or unmanipulated peripheral blood stem cells transplantation with nonmyeloablative conditioning. Acta Clinica Belgica, 61 (2), 113.

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325.

Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328.

JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10.

Oral presentations in conferences with scientific selection committee

Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France.

Kwan, O., Canti, L., Ehx, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (16 November 2023). Utilisation de techniques de biologie des systèmes pour une analyse détaillée de la réponse immunitaire au vaccin à ARN messager BNT162b2 chez les patients ayant bénéficié d'une allogreffe [Paper presentation]. 26ème Congrès Annuel de l'Association Française de Cytométrie 2023, Toulouse, France.

Bodart, G., THYS, M., GANGOLF, M., CUNIN, M.-P., LAMBERT, F., POUSTOVOITOV, A., Beguin, Y., Kolh, P., & Jacques, J. (2022). Développement d’un outil de pilotage des patients oncologiques au CHU de Liège [Paper presentation]. Giseh 2022, Saint-Etienne, France.

Mina, M., Horrion Jil, SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., MALAISE, M., & MALAISE, O. (September 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Belgian Congress of Rheumatology.

Mina, M., Horrion, J., SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., Malaise, M., & MALAISE, O. (March 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Bone Curriculum Symposium 2019.